SV
A
TechnologySemiconductorsUnited States

Astera Labs, Inc. (ALAB) Valuation Assumptions

Review Astera Labs, Inc. (ALAB) valuation assumptions across intrinsic value, DCF, reverse DCF implied growth, EV/EBITDA, P/FCF, and financial trends.

NMS · US · USD

Latest price199.79 USD
30D+68.13%
Price vs model medianLimited model referenceModel median is the median base output from applicable absolute models, excluding Reverse DCF.

Quick answer

What growth is the market currently pricing into ALAB?

At 199.79 USD, TickerVal's reverse DCF setup implies roughly 36.7% annual FCF growth for 10 years for ALAB, using the current normalized FCF base, a 9.5% discount rate, and 3.0% terminal growth. The rest of the page shows valuation assumptions, model differences, and source-data context for research reference.

What price implies

What does the current price imply?

At 199.79 USD, the model implies roughly 36.69% annual FCF growth for 10 years, with required long-term operating margin near 19.33% and terminal growth around 3%. This module is a research reference.

Implied FCF CAGR36.69%

10-year Reverse DCF scenario

Required long-term operating margin19.33%

Five-year median × 0.95

Implied terminal growth3%

From current model assumptions

Discount rate assumption9.5%

Estimated from current sector rules

Adjust assumptions+

Adjust assumptions

Move assumptions to see how the current price implied conditions change.

Forecast horizon10Y

Historical implied expectations

How does today's implied growth compare with history?

Calculated from selected historical prices and current normalized FCF assumptions, not a full point-in-time backtest.

Current implied FCF CAGR36.7%
5Y monthly median27.04%
Current vs 5Y median+9.66 pts

Showing 8 of 10 report price anchors

Report price anchorPrice dateAnchor priceImplied FCF CAGR
Q1-20262026/03/31109.60 USD28.12%
FY20252025/12/31166.36 USD34.04%
Q1-20262025/12/31166.36 USD34.04%
Q3-20252025/09/30195.80 USD36.39%
Q2-20252025/06/3090.42 USD25.45%
Q1-20262025/03/3159.67 USD19.77%
FY20242024/12/31132.45 USD30.79%
Q3-20252024/12/31132.45 USD30.79%
202632.61%

Avg 32.6% · Samples 5

202529.14%

Avg 28.96% · Samples 12

202421.4%

Avg 21.72% · Samples 10

Historical valuation multiples

How have EV/EBITDA and P/FCF changed over the last 5 years?

Annual fiscal-period anchored: month-end prices are paired with the most recent annual fiscal period ending on or before each date, covering the last 5 years (18 monthly samples). Multiples are research references; financial-sector or otherwise non-comparable companies require sector-specific context.

P/FCF

Market cap divided by reported free cash flow.

127x
Near median · P58
Current5Y medianTypical range IQR
5Y median120x
Current127x · P58
5Y low 69.84xCurrent vs median+5.94%5Y high 251x
IQR 95.45–174x · 18 monthly samples

Month-end historical multiples

A date-friendly view for historical EV/EBITDA, P/FCF, and P/E queries.

Showing 8 of 18 month-end samples
Month-endPriceP/EP/FCFEV/EBITDAFiscal period used
2026-05-08199.79 USD164x127x198x2025-12-31
2026-04-30194.74 USD160x124x193x2025-12-31
2026-03-31109.60 USD89.8x69.84x108x2025-12-31
2026-02-27118.83 USD97.37x75.72x117x2025-12-31
2026-01-30150.62 USD123x95.98x149x2025-12-31
2025-12-31166.36 USD136x106x165x2025-12-31
2025-11-28157.57 USD-202x-2024-12-31
2025-10-31186.68 USD-239x-2024-12-31

Valuation overview

How do the valuation assumptions fit together?

Astera Labs, Inc. (ALAB) valuation on TickerVal is designed to help readers understand the operating expectations embedded in the current market price. At 199.79 USD, the page brings intrinsic value analysis, DCF outputs, reverse DCF implied growth, EV/EBITDA, P/FCF, and valuation assumptions into one research view within the Technology sector and the Semiconductors industry. Instead of treating one model as a final answer, TickerVal compares cash-flow, earnings-power, balance-sheet, and relative-multiple lenses so the differences between models are visible. The reverse DCF view currently shows implied growth of 36.7%, while the model median reference sits at a limited composite reference versus the current price. The DCF and reverse DCF sections focus on free cash flow, discount rate, terminal growth, and the long-term growth path implied by the current price. EV/EBITDA and P/FCF provide additional context for capital structure and cash-flow multiples. The financial trends section connects those valuation assumptions back to reported revenue of 853M USD, free cash flow of 282M USD, margins, and balance-sheet facts from public filings. Readers can use the layout to compare assumptions across models before reviewing the underlying source data. This page is intended for transparent research reference, model review, and assumption checking.

Valuation model range vs. current price

Each row shows a model output range, with a vertical line for the current price.

Model output range
DCFCalculated · Limited reference
26.23 USD-60.68 USD
Earnings Power ValueCalculated · Limited reference
8.94 USD-8.94 USD
Graham NumberCalculated · Limited reference
14.44 USD-14.44 USD
Owner EarningsCalculated · Limited reference
15.34 USD-18.43 USD
Current price reference line

Why do valuation models give different answers?

Different models rely on different financial facts. The status blocks show which lenses fit this page data.

ModelFitContext
DCFLimitedUseful when recurring free cash flow history exists; sensitive to growth and discount assumptions.
Owner EarningsLimitedUseful when net income, D&A, and capex support owner-earnings scenarios.
Reverse DCFSuitableShows the FCF growth implied by current price under stated assumptions.
Earnings Power ValueLimitedUseful for mature operating profit, with limited emphasis on growth.
Graham NumberLimitedWorks best when EPS and book value are both positive.
Dividend Discount ModelNot meaningfulNeeds explicit dividend history, which is not included in the current version.
Net-Net Liquidation ValueNot meaningfulRequires current asset and liability detail beyond the current data set.
PEGNot meaningfulA quick growth multiple lens when EPS history is positive.
EV/EBITDALimitedUseful for capital structure context when operating profit is available.
P/FCFLimitedA compact free-cash-flow multiple view for positive FCF years.
P/BLimitedMore useful for asset-heavy balance sheets than asset-light companies.
P/SLimitedA revenue multiple lens when profit or FCF is not stable.
Peer ComparisonNot meaningfulStandardized peer comparisons are not included in the current version.

Which valuation models are being calculated?

Hover each model row to inspect formulas and inputs.

Current price199.79 USD
Model median referenceLimited model reference
Price vs model medianLimited model reference
Price date2026/05/08
The aggregated models are mostly limited-reference views, so the composite range bar is not shown.
Calculated

DCF

Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.

26.23 USD45.07 USD60.68 USD
45.07 USDThis model is a limited scenario reference for this sector.
Calculated

Owner Earnings

Uses net income, D&A, and capex as an owner-earnings proxy.

15.34 USD17.26 USD18.43 USD
17.26 USDCurrent price is 1057.3% above the base model value.
Calculated

Reverse DCF

Solves the forward FCF growth rate implied by the current price.

Implied growth36.7%

Current price implies roughly 36.7% annualized FCF growth.

36.7%Current price implies roughly 36.7% annualized FCF growth.
Calculated

Earnings Power Value

Estimates earnings power value without assuming growth.

8.94 USD8.94 USD8.94 USD
8.94 USDCurrent price is 2134.2% above the base model value.

Updated: 2026/05/10

Which financial trends support the assumptions?

Annual financial metrics with switchable views. · Unit: USD

FY2025 · Dec 2025 report13 records
Revenue853M USD
Net income219M USD
Free cash flow282M USD
CapEx38M USD
Operating cash flow319M USD

Valuation basis and non-recurring items

Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.

Expand

A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.

No structured non-recurring items identified. Valuation currently defaults to reported figures and does not claim one-time gains have been removed.
Ad placement

Which reported financials feed the models?

Financial DetailsShowing latest 5 / 13
PeriodTypeRevenueNet IncomeAdjusted net incomeFree Cash FlowDiluted EPSAdjusted EPS
2025/12/31Annual853M USD219M USD-282M USD1.22-
2024/12/31Annual396M USD-83M USD-102M USD-0.64-
2023/12/31Annual116M USD-26M USD--15M USD-0.71-
2022/12/31Annual80M USD-58M USD--40M USD-1.71-
2021/12/31Annual------

Where does this data come from?

Open to inspect field-level SEC EDGAR source, filing form, and derived notes.

SEC EDGAR

Frequently asked questions

Quick notes on price-implied expectations, model differences, and source data.

What is Astera Labs, Inc.'s intrinsic value?

Astera Labs, Inc.'s intrinsic value on TickerVal is reviewed through DCF outputs, reverse DCF implied growth, EV/EBITDA, P/FCF, valuation assumptions, and financial trends from public filings.

How is ALAB valued on TickerVal?

TickerVal values ALAB by comparing intrinsic value models, DCF and reverse DCF assumptions, cash-flow multiples, earnings-power references, and reported financial trends.

What does the current stock price imply?

The reverse DCF view estimates the free-cash-flow growth path implied by the current stock price under stated discount-rate and terminal-growth assumptions.

Which valuation models are used?

TickerVal uses DCF, reverse DCF, Owner Earnings, EPV, Graham Number, EV/EBITDA, P/FCF, P/B, P/S, and other model references where the underlying data is available.

Is this investment advice?

No. TickerVal does not provide investment advice, ratings, price targets, or buy/sell recommendations.

Early supporter list

Get notified as TickerVal adds saved assumptions.

Join the research reference list for product updates, model notes, and transparent assumption workflows.

Research reference updates only. Not investment advice.

Ad placement
Research reference note

TickerVal is a research workspace, not a financial advisor. Pages on this site do not provide investment, legal, or tax advice and do not contain buy, sell, hold, ratings, price targets, or personalized recommendations. Financial data is derived from public company filings available through SEC EDGAR. TickerVal independently normalizes and computes valuation assumptions; figures may differ from company reports or other providers. TickerVal is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.